The role of intellectual property in the biopharmaceutical sector
The ongoing COVID-19 pandemic has brought about an unprecedented public health challenge: vaccinating the world as quickly as possible.
The drive to vaccinate the global population against COVID-19 is the largest vaccine campaign ever rolled out, characterised by complex production, distribution, access, and administration considerations.
To better understand this resulting dichotomy, this white paper answers the following five key questions, with a focus on applications related to innovation in the life sciences sector and the COVID-19 pandemic:
- What is intellectual property?
- Does intellectual property protection matter?
- Does the protection of intellectual property stimulate innovation?
- Does the protection of intellectual property impact citizens?
- What role can intellectual property protection play in the context of addressing both
- current and future pandemics?
Related news and resources
IFPMA Statement at the closing of the WTO Ministerial Conference in Abu Dhabi
On 1 March, at the end of the 13th WTO Ministerial Conference, IFPMA issued a statement.
Read moreFebruary 2024: Impact of a waiver of intellectual property rights for COVID-19 therapeutics
As discussions on an extension of a waiver of intellectual property (IP) rights on COVID-19 therapeutics continue, latest evidence and data published today explains what the adverse impact of a waiver may be on the entire innovation ecosystem and the consequences it may have on industry’s ability to fight future pandemics.
Read more
WTO Ministerial Conference in Abu Dhabi is an opportunity to strengthen trade and health agenda
On 23 February, ahead of the 13th WTO Ministerial Conference, IFPMA and member associations from 10 countries issued a joint statement calling on trade ministers to commit to a comprehensive trade and health agenda that will strengthen the innovation ecosystem, remove trade barriers, promote trade facilitation, strengthen regulatory systems, and address under-resourced healthcare infrastructure.
Read more